Patents Assigned to Flash Therapeutics, LLC
  • Compounds for treating or inhibiting recurrence of acute myeloid leukemia
    Patent number: 11963960
    Abstract: This invention relates to compounds for treating acute myeloid leukemia or inhibiting recurrence of acute myeloid leukemia and for inhibiting growth of and/or killing leukemic stem cells.
    Type: Grant
    Filed: March 15, 2021
    Date of Patent: April 23, 2024
    Assignee: Flash Therapeutics, LLC
    Inventors: Michael Serrano-Wu, Zhixiong Ye, Kejia Ding